Distinct function of P63 isoforms during embryonic skeletal development

Gene

Volumn 519, Issue 2, 2013, Pages 251-259

  Lu, Yaojuan ^a   Abbassi, Sam ^a   Li, Feifei ^b   Ding, Ming ^a   Wu, Guojun ^c   Gu, Junxia ^d   Zheng, Qiping ^a,d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JIANGSU UNIVERSITY   (China)

Author keywords

Col10a1; Col2a1; Embryonic skeletal development; P63 isoforms; Transgenic mice

Indexed keywords

COLLAGEN 10A1; COLLAGEN TYPE 10; ISOPROTEIN; NP63 ALPHA; PROTEIN P63; TAP63 ALPHA; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE; BONE DEVELOPMENT; CARTILAGE CELL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TRANSACTIVATION; TRANSGENICS; WILD TYPE;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROCYTES; CLONING, MOLECULAR; COLLAGEN TYPE II; COLLAGEN TYPE X; EMBRYONIC DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC MARKERS; GENOTYPE; HUMANS; MICE; MICE, TRANSGENIC; OSTEOGENESIS; PHENOTYPE; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; SOX9 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 84875583877     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.021     Document Type: Article

References (33)

1. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2001, 16(21):2813-2828.
2. Bateman J.F., Boot-Handford R.P., Lamandé S.R. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet. 2009, 10(3):173-183. 10.1038/nrg2520.
3. Bergholz J., Xiao Z.X. Role of p63 in Development, Tumorigenesis and Cancer Progression. Cancer Microenviron. 2012, 5(3):311-322. (Epub 2012 Jul 31). 10.1007/s12307-012-0116-9.
4. Bi W., et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6698-6703. (Epub 2001 May 22).
5. Candi E., et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 2007, 6(3):274-285. (Epub 2007 Feb 3).
6. Cheng A., Genever P.G. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J. Bone Miner. Res. 2010, 25:2404-2013.
7. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol. 2001, 13(6):721-727. (Review).
8. Ding M., et al. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development. J. Cell. Physiol. 2012, 227(10):3446-3456. 10.1002/jcp.24045.
9. Hattori T., et al. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 2010, 137:901-911.
10. Hsiao Y.C., et al. Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter. Genesis 2004, 39(2):122-129.
11. Koster M.I., Kim S., Mills A.A., DeMayo F.J., Roop D.R. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004, 18(2):126-131. (Epub 2004 Jan 16).
12. Levrero M., De Laurenzi V., Costanzo A., Gong J., Wang J.Y., Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci. 2000, 113(Pt. 10):1661-1670.
13. Li F., et al. Putative function of TAP63α during endochondral bone formation. Gene 2012, 495(2):95-103. (Epub 2012 Jan 5).
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
15. Mangiulli M., et al. Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res. 2009, 37(18):6092-6104. (Epub 2009 Aug 21).
16. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398(6729):708-713.
17. Moll U.M., Slade N. p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2004, 2(7):371-386.
18. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002, 16(12):1446-1465.
19. Otto F., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
20. Ovchinnikov D. Alcian blue/alizarin red staining of cartilage and bone in mouse. Cold Spring Harb. Protoc. 2009, 3. (pdb.prot5170).
21. Petitjean A., et al. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis 2008, 29(2):273-281. (Epub 2007 Nov 28).
22. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
23. Romano R.A., et al. δNp63 knockout mice reveal its indispensable role as a master regulator of epithelial. Development 2012, 139(4):772-782.
24. Rouleau M., et al. TAp63 is important for cardiac differentiation of embryonic stem cells and heart Development. Stem Cells 2011, 29(11):1672-1683. 10.1002/stem.723.
25. van Bokhoven H., et al. p63 Gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 2001, 69(3):481-492. (Epub 2001 Jul 17).
26. Wu G., et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 2003, 15;63(10):2351-2357.
27. Wu G., et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res. 2005, 65(3):758-766.
28. Wu Q., Chen D., Zuscik M.J., O'Keefe R.J., Rosier R.N. Overexpression of Smurf2 stimulates endochondral ossification through upregulation of beta-catenin. J. Bone Miner. Res. 2008, 23(4):552-563.
29. Yang A., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398(6729):714-718.
30. Zheng Q., et al. Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. J. Bone Miner. Res. 2009, 24:1022-1032.
31. Zhou G., et al. A 182bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell Sci. 1995, (Pt. 12):3677-3684.
32. Zhou G., et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19004-19009.
33. Zufferey R., Donello J.E., Trono D., Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 1999, 73(4):2886-2892.